VANCOUVER, BC, Oct. 26, 2021 /CNW/ - Numinus Wellness Inc.
("Numinus" or the "Company") (TSXV: NUMI), a mental health care
company advancing innovative treatments and safe, evidence-based
psychedelic-assisted therapies, today announced that it will
participate in two upcoming events hosted by Microdose:
- Psychedelic Capital to be held virtually on Thursday, October 28, 2021. Payton Nyquvest, Founder and CEO of Numinus,
will present at 1:45 p.m. ET. To
attend, please register here.
- Wonderland: Miami to be held
at the Adrienne Arsht Center for the Performing Arts in
Miami, FL on November 8-9, 2021. Mr. Nyquvest and Dr.
Evan Lewis, Founder & Director
of the Neurology Centre of Toronto, will give a presentation called
Psychedelic Neurology in the Treatment of Trauma on
Monday, November 8 at 4:40 p.m. ET. In addition, Sharan Sidhu, Science Officer & General
Manager of Numinus, will participate in the Patent Wars
panel on Tuesday, November 9 at
4:30 p.m. ET. To attend, please
For more information about the events or to schedule a
one-on-one meeting with Numinus' management, please contact KCSA
Strategic Communications at NuminusIR@kcsa.com.
Numinus Wellness helps people to heal
and be well through the development and delivery of innovative
mental health care and access to safe, evidence-based
psychedelic-assisted therapies. The Numinus model – including
psychedelic production, research and clinic care – is at the
forefront of a transformation aimed at healing rather than managing
symptoms for depression, anxiety, trauma, pain and substance use.
At Numinus, we are leading the integration of psychedelic-assisted
therapies into mainstream clinical practice and building the
foundation for a healthier society.
Learn more at www.numinus.com and follow us
on LinkedIn, Facebook, Twitter,
Statements and other information contained in this press release
about anticipated future events constitute forward-looking
statements. Forward-looking statements are often, but not always,
identified by the use of words such as "seek", "anticipate",
"believe", "plan", "estimate", "expect" and "intend" and statements
that an event "may", "will", "should", "could" or "might" occur or
other similar expressions. Forward-looking statements are subject
to risks and uncertainties and other factors that could cause
actual results to differ materially from those contained in the
forward-looking statements. Forward-looking statements are based on
estimates and opinions of management at the date the statements are
made. The Company does not undertake any obligation to update
forward-looking statements even if circumstances or management's
estimates or opinions should change except as required by
applicable laws. Investors should not place undue reliance on
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Numinus Wellness Inc.